Skip to main content
. 2012 Apr;50(4):1433–1436. doi: 10.1128/JCM.06855-11

Table 1.

Clinical features of the four patients with blaNDM-1-carrying Klebsiella pneumoniaea

Patient Age (yr)/gender and underlying disease Admission date, date discharged or expired, and clinical outcome Ward (dates of hospital stayb) Period of isolation of NDMKP, specimen type, and pathogenicity Carbapenem(s) administered before isolation of NDMKP (no. of days before isolation)
1 71/F; pyogenic spondylitis 3 June 2010; 21 January 2011; improved GW124 (3 June–5 July), MICU1 (5 July–16 July), GW134 (16 July–30 July), MICU1 (30 July–3 August), GW134 (3 August–21 January 2011) 5 November 2010–31 December 2010; stool; colonizer Meropenem (8)
2 52/M; dermatomyositis interstitial lung disease 7 October 2010; 16 December 2010; expired from pneumothorax MICU1 (7 October–12 October), MICU2 (12 October–16 December) 8 November 2010–12 November 2010; urine; colonizer Meropenem (16)
3 71/M; vertebral osteomyelitis 31 August 2010; 15 December 2010; improved GW134 (31 August–2 September), MICU2 (2 September–17 September), GW134 (17 September–15 December) 16 November 2010/stool/colonizer Meropenem (22), ertapenem (13)
4 59/M; liver transplantation due to HBV-associated liver cirrhosis 28 July 2010; July 2011; improved GW91 (28 July–3 August), MICU1 (3 August–12 August), SICU (12 August–3 September), GW102 (3 September–19 September), SICU (19 September–26 September), GW102/SICU (26 September to last follow-up on 30 June 2011) 30 November 2010–6 December 2010/urine/colonizer; 15 December 2010–22 January 2011/stool/colonizer Meropenem (47)
a

NDMKP, NDM-1-producing Klebsiella pneumoniae; GW, general ward; MICU, medical intensive care unit; SICU, surgical intensive care unit; M, male; F, female.

b

In 2010 unless specified.